SO
55
-7
MPC
44
3
HD
58
-3
OI
42
4
DUK
57
-5
BAC
50
-6
PRU
64
-3
AIG
45
-5
IR
69
4
DVA
71
-4
MET
67
-5
CI
59
-4
AEE
58
-8
ITW
70
3
KMI
59
-8
PFE
26
-2
ADP
66
-3
KEY
40
-3
EFX
41
-3
DTE
54
-4
SO
55
-7
MPC
44
3
HD
58
-3
OI
42
4
DUK
57
-5
BAC
50
-6
PRU
64
-3
AIG
45
-5
IR
69
4
DVA
71
-4
MET
67
-5
CI
59
-4
AEE
58
-8
ITW
70
3
KMI
59
-8
PFE
26
-2
ADP
66
-3
KEY
40
-3
EFX
41
-3
DTE
54
-4
Financhill
Back

Regeneron Pharmaceuticals Quote, Financials, Valuation and Earnings

32,481% Growth: Invest in the Smartphone Revolution @ $0.26/Share

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44

REGN
Regeneron Pharmaceuticals

Last Price:
755.50
Seasonality Move:
21.03%

7 Day Trial

ALL ACCESS PASS

$ 7

Invest. Do Good. Get Rewarded. Just $0.26/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Regeneron Pharmaceuticals Price Quote

$755.50
-6.84 (-0.9%)
(Updated: December 3, 2024 at 11:50 AM ET)

Regeneron Pharmaceuticals Key Stats

Sell
44
Regeneron Pharmaceuticals (REGN) is a Sell
Day range:
$748.41 - $763.89
52-week range:
$735.95 - $1,211.20
Dividend yield:
0%
P/E ratio:
21.93
P/S ratio:
6.34
P/B ratio:
2.86%
Volume:
864.7K
Avg. volume:
868.6K
1-year change:
-6.45%
Market cap:
$83.8B
Revenue:
$13.1B
EPS:
$40.41

How Much Does Regeneron Pharmaceuticals Make?

Is Regeneron Pharmaceuticals Growing As A Company?

Regeneron Pharmaceuticals Stock Price Performance

What Is Regeneron Pharmaceuticals 52-Week High & Low?

Regeneron Pharmaceuticals Price To Free Cash Flow

Is It Risky To Buy Regeneron Pharmaceuticals?

Is Regeneron Pharmaceuticals Cash Flow Positive?

  • What Is REGN Cash Flow From Operations?
    Cash flow from operations (TTM) is $4.2B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.5B
  • What Is Regeneron Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$2.9B

Regeneron Pharmaceuticals Return On Invested Capital

  • Is Management Doing A Good Job?
    REGN return on invested capital is 16.02%
  • What Is Regeneron Pharmaceuticals Return On Assets?
    ROA measures how assets are converting to revenues and is 13.44%
  • What Is REGN Return On Equity?
    ROE is a measure of profitability and is 17.19%

Regeneron Pharmaceuticals Earnings Date & Stock Price

Regeneron Pharmaceuticals Competitors

Regeneron Pharmaceuticals Dividend Yield

Regeneron Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 29.81% 6.54%
Revenue: 10.65% 1.47%

Analyst Recommendations

Buy Recommendations: 11
Hold Recommendations: 7
Sell Recommendations: 0
Price Target: 1,078.63
Upside from Last Price: 41.49%

Major Shareholders

  • How many REGN shares are owned by institutional investors?
    171.4M REGN shares are owned by institutional investors
  • How many REGN shares are owned by insiders?
    2.1M REGN shares are owned by insiders